Through a $4.5 million award from the National Institutes of Health (NIH), two researchers in the Herbert Wertheim College of Engineering are working to advance the therapeutic intervention known as “neuromodulation,” fine-tuning electronic stimulation inside the body by creating next-generation electrodes that will deliver the equivalent of high fidelity for the central nervous system.
The University Term Professorship was established in 2016 and is presented to 250 eligible faculty members annually. Selection of the professorships is based on an assessment of academic accomplishment by either a faculty advisory committee and/or the department chair and approved by the dean of the Herbert Wertheim College of Engineering.
Researchers at the University of Florida, including Fan Ren, Ph.D., a distinguished professor in the Department of Chemical Engineering, have helped develop a COVID-19 testing device that can detect coronavirus infection in as little as 30 seconds as sensitively and accurately as a PCR.
University of Florida researchers have invented a test that can determine within 10-15 minutes whether patients test positive for COVID and, if so, which of the five known variants of concern they have.
UF engineers reach semi-finals in XPRIZE Contest for new COVID-19 test methods; their CRISPR-ENHANCE methodology published in Nature Communications journal
Piyush Jain, Ph.D., CHE, has been working on a test for the novel coronavirus that can be administered at home in less than 30 minutes.
The Herbert Wertheim College of Engineering at the University of Florida is pleased to announce that six faculty members have received National Science Foundation (NSF) Early CAREER Awards in 2020.
The UF Herbert Wertheim College of Engineering has once again ranked among the top 25 public university graduate engineering programs in the U.S., according to the 2021 U.S. News & World Report (USNWR) Best Graduate Schools rankings.
David Hibbitts, Ph.D., an assistant professor in the Department of Chemical Engineering, has been named a National Science Foundation (NSF) Faculty Early Career Development (CAREER) Program Award winner.
For the first time in the United States, a gene editing tool has been used to treat advanced cancer in three patients and showed promising early results in a pilot phase 1 clinical trial.